What Is the Success Rate of Laser Prostate Surgery?

Laser prostate surgery relieves urinary symptoms successfully in the vast majority of men treated for benign prostatic hyperplasia (BPH), with patient satisfaction rates above 90% and long-term reoperation rates generally in the single digits. The specific numbers depend on which laser technique is used, how “success” is defined, and how many years out you look. Because there are several distinct laser procedures with different mechanisms, the picture is more nuanced than a single headline figure can capture.

How Surgeons Actually Measure Success

When researchers report a “success rate” for laser prostate surgery, they are not using a single pass-fail test. The most widely adopted framework grades outcomes across three domains: symptom severity (measured by the International Prostate Symptom Score, or IPSS), urinary flow rate, and quality of life. Each domain gets a grade from excellent to poor, and the overall result is the median of the three. Treatment is typically considered successful if that overall grade comes out as “fair or greater,” though some studies use a stricter bar of “good or greater.”¹ This grading system was originally developed for evaluating any BPH surgery and has been applied across laser types.²

What this means for you as a patient is that “success” is not just about whether you can urinate afterward. It folds in how much your stream improves, how often you wake up at night, and whether your overall quality of life gets better. By these composite measures, laser procedures perform well, but the details vary by technique.

The Major Laser Techniques and Their Track Records

Three laser platforms dominate the field, each working a bit differently. Holmium laser enucleation of the prostate (HoLEP) uses a holmium laser to peel the obstructing tissue away from the prostate capsule in large pieces, which are then broken up and removed. GreenLight photoselective vaporization (PVP) uses a high-powered green-wavelength laser to vaporize tissue. Thulium laser enucleation (ThuLEP) works similarly to HoLEP but uses a continuous-wave thulium laser, which cuts tissue in a slightly different fashion. All three have strong evidence behind them, but their strengths and weaknesses differ.

HoLEP is often considered the reference standard among laser options. A network meta-analysis comparing various laser techniques found that holmium laser enucleation was the best performer for improving urinary flow rate and reducing residual urine volume, while thulium laser techniques showed the greatest improvement in symptom scores and the shortest hospital stays.³ A systematic review of holmium laser procedures found they were similarly effective to the traditional gold standard, transurethral resection of the prostate (TURP), for symptom relief, while showing safety advantages in blood loss, transfusion rates, catheter time, and hospital stay.⁴

GreenLight PVP has particular appeal for men who are in urinary retention, meaning they cannot empty their bladder at all and depend on a catheter. In a study of men in retention who underwent GreenLight surgery, about 83% were able to urinate on their first attempt after the procedure, and by 12 months roughly 88% remained catheter-free.⁵

Thulium laser enucleation has earned a reputation for efficiency. In a large series of over 230 patients, ThuLEP kept most men catheterized for only about a day, with hospital stays of 24 to 36 hours for the vast majority. Symptom scores dropped sharply and prostate size was reduced substantially.⁶ For large glands over 80 mL, thulium enucleation showed symptom scores dropping from the high 20s to the single digits, with urinary flow rates more than doubling.⁷

How Long the Results Last

Short-term success rates look excellent for all three laser types, but the question men really want answered is whether the improvement holds up over years. This is where reoperation rates become the most useful metric: if you need a second procedure, the first one did not fully succeed.

A systematic review pooling data from many studies found that reoperation rates at five years were about 7% for HoLEP, roughly 7% for GreenLight PVP, and around 8% for thulium enucleation.⁸ Those numbers are broadly similar at the five-year mark, but beyond that, differences emerge. A separate systematic review comparing HoLEP and GreenLight PVP beyond five years found that HoLEP maintained durable outcomes with a mean reoperation rate of about 4%, while GreenLight PVP’s reoperation rates were higher, averaging around 13% over longer follow-up. Newer 180-watt GreenLight models did show better durability than older ones.⁹

Thulium enucleation shows similar long-term staying power to HoLEP. In a single-center study following over 1,000 patients for up to 12 years, only about 4% needed a repeat prostate procedure, and the estimated cumulative reoperation rate at 10 years was roughly 6%.¹⁰

The takeaway: enucleation techniques (HoLEP and ThuLEP) tend to remove more tissue and produce more durable results than vaporization approaches. If long-term freedom from reoperation is your priority, enucleation has a slight edge.

What Happens to Sexual Function

This is one of the first things men ask about, and the honest answer has a split personality. Erectile function is largely preserved, but ejaculatory function often is not.

After HoLEP, studies consistently show no significant change in erection quality on average. However, about 70% of men lose antegrade ejaculation, meaning semen goes backward into the bladder during orgasm rather than being expelled normally. This is not dangerous, but it is permanent and affects fertility. A smaller proportion of men, roughly 12%, reported a meaningful decline in erection scores, while about 7% actually reported improvement.¹¹

After GreenLight PVP, erectile function tends to decline somewhat, with the sharpest drops seen in men who had normal erections before surgery. Preoperative body mass index was identified as the only independent risk factor for meaningful erectile decline after PVP.¹²

Thulium enucleation may offer an advantage here. One study found no significant change in erectile function and reported that over half of ThuLEP patients retained normal antegrade ejaculation, a much higher rate than what is typically seen after HoLEP or TURP.¹³ If preserving ejaculation matters to you, this is worth discussing with your urologist, though this finding comes from a relatively small evidence base and the technique varies by surgeon.

Temporary and Lasting Urinary Side Effects

Some degree of urinary leakage after laser prostate surgery is common in the first weeks, and it is almost always temporary. In a large single-surgeon series of nearly 600 HoLEP patients, about 9% developed temporary stress urinary incontinence. Of those, the vast majority resolved within six weeks, and the rest cleared up by three months. Only about 1.5% developed long-term leakage that required further treatment.¹⁴

Your anatomy plays a role in how quickly continence returns. Research has shown that the length of the membranous urethra, a stretch of the urinary channel below the prostate, strongly predicts early continence recovery. Men with a longer membranous urethra had an 80% continence rate one month after HoLEP, while those with a shorter one had only a 30% rate at the same time point. By six months, both groups converged at about 97%.¹⁵ The reassuring part is that nearly everyone gets there eventually.

When Laser Surgery Works Best and When It Falls Short

Not every man sees dramatic improvement. Research into non-responders has identified a pattern: men who start with severe symptoms that are dominated by storage problems (frequent urination, urgency, nighttime waking) rather than voiding problems (weak stream, straining) tend to have a slower and less complete recovery. These men often experience a temporary rebound of storage symptoms around six to eight weeks after surgery before gradually improving.¹⁶ High baseline storage symptom scores, longer operative times, and less tissue removal relative to the original prostate size all predicted less improvement in post-surgical storage symptoms, regardless of the laser technique used.¹⁷

This makes sense when you think about it: laser surgery removes the tissue blocking the channel, but if your bladder muscle itself is overactive or weakened from years of straining, removing the blockage will not fully fix the problem. Men whose symptoms are mainly about a weak stream and difficulty emptying tend to get the most dramatic results.

Very Large Prostates

One of the strongest selling points of laser enucleation is that it works well for prostates of any size, including very large ones that traditionally required open surgery. A study specifically looking at HoLEP for prostates over 150 mL concluded that the procedure was both safe and effective, arguing it should be considered the gold standard for large glands.¹⁸ A meta-analysis comparing laser enucleation to minimally invasive open techniques confirmed that both were safe and effective, but laser enucleation had shorter catheterization times and hospital stays.¹⁹ For men with very large prostates, HoLEP or ThuLEP can accomplish in a few hours with a laser fiber what once required an abdominal incision and days in the hospital.

Men on Blood Thinners

Laser prostate surgery has a well-established safety profile for men who take anticoagulant medications and cannot easily stop them. GreenLight PVP, in particular, has been highlighted as a strong option for these patients. A study found that men on ongoing oral anticoagulation who underwent PVP had virtually identical blood loss and complication rates to those not on blood thinners, with no patients needing a blood transfusion. The symptom improvements were robust, ranging from 60 to 70% improvement in symptom scores over two years.²⁰

HoLEP has also been studied in anticoagulated patients. Symptom scores, flow rates, and quality of life all improved significantly by one month and continued improving. A small number required blood transfusion in the early postoperative period, mostly when anticoagulant therapy was restarted, but there were no major complications or blood clot events.²¹

The Surgeon’s Experience Matters More Than You Might Think

Laser prostate surgery, especially enucleation, has a real learning curve, and the surgeon’s case volume affects your outcome. A multicenter study attempting to evaluate how quickly surgeons could learn HoLEP found sobering results: of nine training centers, three abandoned the technique entirely before the study ended due to complications, and overall, procedures met their success criteria only about 44% of the time across inexperienced surgeons.²² A single-center study showed that enucleation efficiency stabilized after about 30 cases, but early in the learning curve, conversion to traditional resection happened in 30% of procedures, compared to 12% after the learning curve was passed.²³

For GreenLight enucleation, a large international study found that surgical experience was linked to shorter operative times, fewer complications, and better symptom improvement at three months. The learning curve was steepest over the first 100 cases, with a plateau around 200.²⁴ The practical implication is clear: ask your surgeon how many laser prostate procedures they have performed. A surgeon past their learning curve will deliver meaningfully better results.

Late Complications to Know About

Beyond the immediate recovery period, the main late complications to be aware of are urethral strictures and bladder neck contractures, both of which are scarring problems that can narrow the urinary channel months or years after surgery. After HoLEP, urethral strictures develop in roughly 5% of patients, and bladder neck strictures in about 2%. Most urethral strictures occur within the first two years and are located in the bulbar urethra. Interestingly, smaller prostate volume and less surgeon experience were associated with higher stricture risk.²⁵ In a matched comparison, TURP had a somewhat higher urethral stricture rate (about 8%) than HoLEP (about 5%), though the difference was not statistically significant.²⁶ These strictures are treatable, usually with a minor outpatient procedure, but they are worth knowing about as a possible reason symptoms could return after an initially successful surgery.

Recovery Speed and Same-Day Discharge

One of the practical advantages men care most about is how quickly they can go home and return to normal life. Laser surgery consistently beats TURP on this front. A growing body of evidence supports same-day catheter removal after HoLEP. In pilot and expanded studies, roughly 88 to 91% of patients had their catheter removed and went home the same day as surgery.²⁷²⁸ A prospective study confirmed that about 91% of patients could be discharged on the same day after catheter removal.²⁹ This is a sharp contrast to TURP, which typically requires overnight stays and longer catheterization.

Patient Satisfaction Numbers

Perhaps the most telling success metric is what patients themselves say afterward. In a prospective study of over 300 HoLEP patients, about 92% reported being satisfied with the surgery. When asked whether they would undergo the procedure again if they had to make the decision over, 94% said yes. Virtually all patients, over 99%, reported that their condition had improved.³⁰ These are high numbers for any elective surgery, and they reflect the real-world experience that most men feel meaningfully better after the procedure.

Newer Laser Technology and Where Things Are Heading

The laser hardware itself continues to evolve. One recent advance is MOSES technology, a pulse-delivery modification for holmium lasers that sends energy into tissue more efficiently. A double-blind randomized trial found that MOSES-equipped HoLEP (called MoLEP) cut total operative time by about 25 minutes, reduced hemostasis time substantially, and caused less blood loss compared to standard HoLEP.³¹ A systematic review confirmed these intraoperative advantages and noted that MoLEP patients tended to have shorter hospital stays and earlier catheter removal, making it attractive as a day-surgery procedure.³² A randomized trial from a high-volume center showed similar postoperative improvements in urinary function for both groups, with MoLEP achieving faster hemostasis and requiring less bladder irrigation.³³ The functional outcomes are similar, so the benefit is mainly about a smoother, faster procedure and quicker discharge rather than better long-term symptom relief.

Cost Considerations

Laser prostate surgery typically costs more upfront than TURP because of the equipment involved. But the total cost picture often favors the laser. A randomized study found that holmium laser resection cost about 25% less than TURP over the first year when complications, hospital days, and catheter time were factored in, despite equivalent symptom outcomes.³⁴ A separate analysis found that the cost savings of laser prostatectomy over TURP came primarily from fewer complications, less postoperative bleeding, shorter hospital stays, and lower retreatment rates.³⁵ For hospitals that perform enough cases per year to justify the laser equipment purchase, the economics favor laser surgery over time.